Delivery Order SPE2DB20D1004-SPE2DB23FF8P9

Award Date 5/10/23
Potential Completion Date 5/11/23
Potential Value $3.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.06 Firm Fixed Price Delivery Order contract is for the supply of CHLORTHALIDONE 25 MG TABLET 100S medical tablets, with a period of performance through May 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,808.37 firm fixed-price delivery order is for the supply of 4,560,651,696 units of the medication chlorthalidone 25 mg tablets. The contract has an ultimate completion date of April 20, 2023. This award is a task order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $18,967.65 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of chlorthalidone 25mg tablets, a generic pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, as a firm fixed price delivery order. The contract has a ceiling value of $2,778.31 and a performance period through March 15, 2024. No set-aside designation was used for this contract....
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF8NT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,292.66 firm fixed-price delivery order is for the supply of 4,567,692,282 units of the medication Chlorthalidone 25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,579.16, is for the delivery of 4558370948 CHLORTHALIDONE 25 MG TABLET 100S. It is a Firm Fixed Price Delivery Order with a completion date of September 8, 2022. The contract was awarded on September 7, 2022 and does not have a set-aside designation, indicating open...
This federal contract award, valued at $1,107.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,558,614,232 chlorthalidone 25 mg tablets in quantities of 100s, with a completion date of September 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,480.39 contract is for the supply of Chlorthalidone 25 mg tablets to support federal healthcare programs. The award has an ultimate completion date of March 31, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,169.22 firm fixed-price delivery order is for the supply of 4,565,552,136 chlorthalidone 25 mg tablets, which are medical products used for the treatment of various health conditions. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. It is not designated as a set-aside contract. As a major...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF8P9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $3,417.69 Firm Fixed Price contract has a completion date of May 11, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating full and open competition.

Generated 5/9/25, 9:49 AM